as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹213.19
Change
-11.06 (-4.93%)
Open
₹225.5
Prev. Close
₹224.25
Day High
₹226.0
Day Low
₹210.2
Volume Analysis
Traded
9,353
Delivered
5,191
Delivery %
55.5%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹238.52 | ₹232.26 | ₹222.72 | ₹216.46 | ₹206.92 | ₹200.66 | ₹191.12 |
| Fibonacci | ₹232.26 | ₹226.22 | ₹222.5 | ₹216.46 | ₹210.42 | ₹206.7 | ₹200.66 |
| Camarilla | ₹217.54 | ₹216.09 | ₹214.64 | ₹216.46 | ₹211.74 | ₹210.29 | ₹208.85 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+4.44%
1 Week
+2.07%
1 Month
+26.15%
3 Months
+28.78%
6 Months
+48.09%
1 Year
+28.94%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Sector
Chemicals
Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.
TopFund Analysis
Arvee Laboratories I Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 54/100. The strongest factor is Corporate Governance (85/100), while Risk & Volatility (29/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
54/100 — AverageData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Corporate Governance
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Trading window closed from 1 Oct 2026 until two working days after 30 Sep 2026 results.
Mrs. Raina Singh resigned as Company Secretary and Compliance Officer effective 9 September 2026.
Corrigendum corrects trading window closure date from 01/04/2026 to 01/07/2026.
Trading window closed from July 1, 2026 until two working days after 30 June results.
Source: BSE regulatory filings, via Screener.in.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% |
| Promoters | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Arvee Laboratories I Ltd (this stock) | — | — | — | — |
| Solar Industries (i) Ltd | 178,673 | 89.7 | 28.45 | 32.6% |
| Pidilite Industries Ltd | 154,533 | 58.4 | 14.31 | 23.9% |
| Srf Ltd | 75,292 | 33.6 | 5.36 | 14.3% |
| Coromandel Interntl. Ltd | 57,480 | 30.8 | 4.57 | 16.4% |
| Linde India Limited | 52,377 | 95.9 | 12.28 | 13.6% |
| Fact Ltd | 51,552 | 3481.0 | 37.59 | 1.61% |
Which Mutual Funds Hold Arvee Laboratories I Ltd?
Frequently Asked Questions about Arvee Laboratories I Ltd
Arvee Laboratories I Ltd (ARVEE) closed at ₹213.19 on NSE on 25 September 2026, down 11.06 (4.93%) from the previous close.
Arvee Laboratories I Ltd trades on the NSE (National Stock Exchange of India) under the symbol ARVEE.
Arvee Laboratories I Ltd has a TopFund Quality Score of 54/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Arvee Laboratories I Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.